Amanta Healthcare Share Price Today | Stock Price & Amanta Healthcare Share Screener
As of June 15, 2026, the live Amanta Healthcare share price (NSE: AMANTA) is ₹157.14 on NSE and ₹201.60 on BSE, up 3.50% from the previous close, with shares trading between ₹154.00 and ₹161.00 in today's trading session, and a 52-week range of ₹95.03–₹157.14. Check AMANTA 52-week performance for the annual price range and momentum. Use the Amanta Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Amanta Healthcare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹294 and net income of ₹15, with EBITDA of ₹60, an operating margin of 20.0% and a profit margin of 5.1%.
Amanta Healthcare Share Price Chart
Track the current stock price of Amanta Healthcare with an interactive chart. Analyse AMANTA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Amanta Healthcare stock quote in one place.
The quote of ₹157.14 sits between the 52-week low of ₹95.03 and the 52-week high of ₹157.14, and the latest session moved 3.50% from the previous close.
Amanta Healthcare Company Profile - Fundamental Screener
Screen Amanta Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AMANTA shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE084K01015.
Company Details
Classification
Identifiers and Leadership
Amanta Healthcare Balance Sheet Screener
Screen AMANTA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹558, up from ₹382 in 2025.
Latest statistics put total assets at ₹558 and shareholder funds at ₹220, with a leverage ratio of 1.33.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Assets |
|||||||
| Total Assets | 558 | 382 | 352 | 374 | 392 | 392 | 388 |
| Current Assets | 239 | 138 | 118 | 131 | 136 | 131 | 105 |
| Fixed Assets | 207 | 217 | 228 | 232 | 240 | 242 | 244 |
Liabilities |
|||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 197 | 170 | 184 | 214 | 214 | 262 | 285 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||||
| Total Equity | 220 | 96 | 66 | 63 | 72 | 7 | 29 |
| Share Capital | 39 | 29 | 27 | 27 | 37 | 27 | 27 |
| Reserves & Surplus | 181 | 68 | 40 | 36 | 36 | -20 | 2 |
Amanta Healthcare Income Statement Screener - Profit & Revenue Analysis
Screen Amanta Healthcare income statement and profit fundamentals. Analyze AMANTA quarterly results. Amanta Healthcare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹294 and net profit was ₹15, equal to earnings per unit of ₹4.20, at an operating margin of 20%.
In that period expenses were ₹234, interest cost ₹21 and tax ₹7. The next period listed, 2026-March, shows revenue of ₹291 and net profit of ₹15.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | ||||||||
| Revenue | 294 | 291 | 276 | 282 | 263 | 227 | 172 | 187 |
| Expenses | 234 | 228 | 215 | 223 | 206 | 173 | 133 | 147 |
Operating Costs and Margins | ||||||||
| EBITDA | 60 | 63 | 61 | 59 | 56 | 54 | 39 | 40 |
| Operating Profit % | 20.00% | 21.00% | 22.00% | 21.00% | 20.00% | 23.00% | 22.00% | 20.00% |
| Depreciation | 19 | 19 | 18 | 20 | 18 | 17 | 17 | 17 |
| Interest | 21 | 21 | 28 | 34 | 35 | 49 | 40 | 38 |
Profit and Earnings | ||||||||
| Profit Before Tax | 21 | 21 | 15 | 5 | 3 | 62 | -18 | -15 |
| Tax | 7 | 6 | 4 | 2 | 5 | 7 | 4 | 4 |
| Net Profit | 15 | 15 | 11 | 4 | -2 | 55 | -22 | -19 |
| EPS | 4.20 | 4.33 | 3.71 | 1.35 | -0.79 | 20.54 | -8.14 | -7.04 |
Amanta Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen AMANTA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹49, and net cash flow was an inflow of ₹81.
Over the same period, investing activities used ₹94 and financing activities provided ₹126.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | |||||||
| Operating Activities | 49 | 47 | 58 | 43 | 62 | 31 | 38 |
| Investing Activities | -94 | -25 | -10 | -7 | -6 | -13 | -9 |
Financing and Net Cash | |||||||
| Financing Activities | 126 | -24 | -46 | -42 | -50 | -18 | -37 |
| Net Cash Flow | 81 | -1 | 1 | -6 | 6 | 0 | -8 |
Amanta Healthcare Shareholding Pattern Screener
See Amanta Healthcare shareholding pattern with promoter, FII, and DII holdings. Check Amanta Healthcare promoter holding and ownership changes for AMANTA on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Jun, promoters held 63.80%, foreign institutions 0.43%, domestic institutions 12.92% and the public 17.45%, spread across 12,612 shareholders.
The shareholder count was 12,612 in 2026-Jun, compared with 15,222 in 2026-Mar.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Aug | 2025-Jun | 2025-Feb | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 63.80% | 63.72% | 63.56% | 63.56% | 85.60% | 63.56% | 85.52% | 85.52% |
Institutional Investors | ||||||||
| FII Holding | 0.43% | 0.85% | 1.10% | 1.00% | 0.00% | 2.21% | 0.00% | 0.00% |
| DII Holding | 12.92% | 12.88% | 11.24% | 11.34% | 0.00% | 12.22% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 17.45% | 16.00% | 16.91% | 17.35% | 0.00% | 20.28% | 0.00% | 0.00% |
| Other Holding | 5.39% | 6.56% | 7.19% | 6.75% | 14.40% | 1.74% | 14.48% | 14.48% |
| Shareholder Count | 12,612 | 15,222 | 16,181 | 360 | 361 | 30,695 | 200 | 192 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Amanta Healthcare. Amanta Healthcare dividend yield can be compared with peers and other stocks in the market.
Amanta Healthcare Stock Index Membership - Nifty & Sensex
See which indices include Amanta Healthcare stock. Check AMANTA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Amanta Healthcare Market Events Screener - Corporate Actions
Get Amanta Healthcare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Amanta Healthcare stock events that may affect AMANTA share price, along with derivatives, futures and options activity and sector gainers.
6 corporate actions are listed, the most recent entry being Annual General Meeting dated September 16, 2026, with a record date of September 16, 2026.
It is followed by Quarterly Result Announcement dated August 5, 2026 and Quarterly Result Announcement dated May 19, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-16 | 2026-09-16 | Annual General Meeting | NA | 13.97% |
| 2026-08-05 | 2026-08-05 | Quarterly Result Announcement | NA | 6.95% |
| 2026-05-19 | 2026-05-19 | Quarterly Result Announcement | NA | -9.66% |
| 2026-02-10 | 2026-02-10 | Quarterly Result Announcement | NA | 1.14% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -1.51% |
| 2025-09-26 | 2025-09-26 | Quarterly Result Announcement | NA | -0.50% |
Amanta Healthcare Competitors Screener - Peer Stocks Comparison
Screen AMANTA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 447,476 | 36.83 | 61,674 | 12.69% | 11,565 | 47.42 |
| Divis Laboratories | 250,363 | 86.00 | 11,067 | 13.95% | 2,568 | 58.71 |
| Torrent Pharmaceuticals | 186,152 | 86.72 | 13,886 | 20.34% | 2,138 | 48.14 |
| Zydus Life Science | 119,750 | 25.96 | 27,658 | 17.64% | 5,026 | 61.81 |
| Cipla | 111,428 | 33.29 | 29,045 | 2.24% | 3,870 | 44.03 |
| Laurus Labs | 106,928 | 98.39 | 6,868 | 22.01% | 890 | 58.00 |
| Mankind Pharma | 105,120 | 50.84 | 14,636 | 14.85% | 1,938 | 64.24 |
| Dr Reddys Laboratories | 104,494 | 32.77 | 35,059 | 3.90% | 4,158 | 69.59 |
| Aurobindo Pharma | 97,682 | 26.41 | 34,145 | 5.56% | 3,503 | 54.69 |
| Lupin | 93,841 | 16.97 | 29,039 | 26.75% | 5,356 | 34.02 |
Amanta Healthcare Company Announcements - News & Reports Screener
Screen AMANTA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 1, 2026.
The next most recent announcements are dated September 16, 2026 and September 16, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-01 | Closure of Trading Window | - |
| 2026-09-16 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-16 | Shareholder Meeting - Scrutinizers Report | - |
| 2026-09-16 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-09-16 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-03 | Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 | - |
| 2026-09-02 | Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Amanta Healthcare Limited Announces Commissioning Of New Steriport Line | - |
| 2026-08-25 | Intimation - Regulation 36(1)(B) Of The SEBI Listing Regulations | - |
| 2026-08-25 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-24 | Annual Report For Financial Year 2025-26 | - |
| 2026-08-24 | Notice Of 31St Annual General Meeting And Annual Report For F.Y. 2025-26 | - |
| 2026-08-24 | Reg. 34 (1) Annual Report. | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-08 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-08 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-08-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-05 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-05 | Statement Of Deviation Or Variation In Utilization Of Funds If Any Under Regulation 32 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI Listing Regulations") | - |
| 2026-08-05 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹157.14, within a 52-week range of ₹95.03 to ₹157.14. The P/E ratio is 49.18 and the P/B ratio is 3.28, with earnings per unit of ₹4.33. Market capitalisation stands at ₹724.80 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 7 balance sheet periods, 8 income statement periods, 7 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.